Clinical trials
Completed Mumps trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 8 |
| 2007 | 6 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 7 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 4 |
| 2020 | 2 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 61 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 21 |
| Merck Sharp & Dohme LLC | 17 |
| Sanofi Pasteur, a Sanofi Company | 5 |
| Sinovac (Dalian) Vaccine Technology Co., Ltd. | 3 |
| The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 3 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centers for Disease Control and Prevention, China | 1 |
| Institute of Medical Biology, Chinese Academy of Medical Sciences | 1 |
| Jiangsu Province Centers for Disease Control and Prevention | 1 |
| Liaoning Chengda Biotechnology CO., LTD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mumps | 61 |
| Measles | 55 |
| Rubella | 53 |
| Chickenpox | 36 |
| Haemophilus Infections | 4 |
| Encephalitis, Japanese | 3 |
| Meningitis, Meningococcal | 3 |
| Hepatitis A | 2 |
| Diphtheria | 1 |
| Fever | 1 |
Trials
Showing 51 to 61 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.